Venous thromboembolic diseases: diagnosis, management and thrombophilia testing

amended 2020] 1.9.5 Do not routinely offer thrombophilia testing to first-degree relatives of people with a history of DVT or PE and thrombophilia. [2012] Terms used in this guideline Active cancer Receiving active antimitotic treatment; or diagnosed within the past 6 months; or recurrent or metastatic; or inoperable. Excludes squamous skin cancer and basal cell carcinoma. Estimated creatinine clearance Creatinine clearance estimated using the Cockcroft and Gault formula; see the BNF's information on prescribing in renal impairment. Provoked DVT or PE DVT or PE in a person with a recent (within 3 months) and transient major clinical risk factor for VTE, such as surgery, trauma, significant immobility (bedbound, unable to walk unaided or likely to spend a substantial proportion of the day in bed or in a chair), pregnancy or puerperium â€“ or in a person who is having hormonal therapy (combined oral contraceptive pill or hormone replacement therapy). Proximal DVT DVT at or above the level of the popliteal trifurcation area. Unprovoked DVT or PE DVT or PE in a person with no recent major clinical risk factor for VTE (see provoked DVT or PE) who is not having hormonal therapy (combined oral contraceptive pill or hormone replacement therapy).
